to obtain cover under a statutory sickness insurance scheme or administrative provisions

Accelerating the creation of the necessary framework conditions and demand, which will need to include improving rules for clinical trials and testing, fast-tracking assessment procedures of new medicines by the European Medicines Agency, patenting and patent protection, regulatory requirements such as measures to protect medical and personal data, reimbursement through national health insurance schemes and co-ordinated procurements by the public sector (networks of public authorities), ensuring interoperability and setting standards and reference specifications for new equipment and services for telemedicine and independent living, sett ...[+++]ing up a fund for care innovation and for “orphan diseases”, and tackling possible market access obstacles in third countries.

Examples of policy measures taken since 2001 include the funding of genome research to fight antibiotic resistance; the establishment of a joint EU surveillance and early warning networks for communicable diseases; the adoption of a proposal for a new EU regulatory framework for chemicals (REACH); the adoption of the European Environment and Health Action Plan 2004-2010; and the setting up of a European Food Safety Authority (EFSA) and European Centre on Communicable Diseases (ECDC).

4. Payments must be made in relation to diseases or pests for which Community or national provisions exist, whether laid down by law, regulation or administrative action.

Unless after carrying out a regulatory impact assessment the Commission decides otherwise, Member States shall, by .* [six years after the date of entry into force of this Directive], ensure that a facility is established to provide automated redirection of payments from one payment account to another payment account within the same Member State combined with automated notifications to payees or payers when their transfers are redirected.